Back to Capital Research Global Investors Capital Research Global Investors

TAKTAK
22 quarters

Position history for Capital Research Global InvestorsCapital Research Global Investors's holdings in TAKEDA PHARMACEUTICAL CO LTD

Capital Research Global Investors holds 19.3M shares of TAK (TAKEDA PHARMACEUTICAL CO LTD), worth $309.3M as of 2026-Q2. The position was increased (+1.0% shares). TAK represents 0.0% of Capital Research Global Investors's portfolio.

Current Value

$309.3M

Current Shares

19.3M

Total Value Change

+$309M

Total Shares Change

+19.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
19.3M
+1.0%
$309.3M0.0%$16.03
31
2026-Q1
Increased
19.1M
+41.6%
$353.8M0.1%$18.08
41
2025-Q4
Increased
13.5M
+0.6%
$210.3M0.0%$15.63
31
2025-Q3
Increased
13.4M
+0.8%
$196.2M0.0%$14.62
31
2025-Q2
Increased
13.3M
+0.7%
$205.5M0.0%$15.10
31
2025-Q1
Increased
13.2M
+0.3%
$196.3M0.0%$14.71
31
2024-Q4
Increased
13.2M
+0.2%
$174.3M0.0%$12.87
30
2024-Q3
Increased
13.1M
+0.1%
$186.8M0.0%$13.89
30
2024-Q2
Increased
13.1M
+0.0%
$169.9M0.0%$12.36
30
2024-Q1
Decreased
13.1M
-8.2%
$182.3M0.0%$13.27
0
2023-Q4
Increased
14.3M
+3.6%
$204M0.1%$13.36
32
2023-Q3
Increased
13.8M
+0.1%
$213.4M0.1%$14.48
30
2023-Q2
Increased
13.8M
+1.5%
$216.6M0.1%$14.70
31
2023-Q1
Increased
13.6M
+407.4%
$223.8M0.1%$15.31
49
2022-Q4
New
2.7M
-
$41.7M0.0%$14.60
40
2021-Q1
Exited
0
-100.0%
$00.0%$17.18
0
2020-Q4
Increased
65,430
+18.2%
$1.2M0.0%$17.02
30
2020-Q3
Increased
55,375
+7.9%
$1M0.0%$16.98
27
2020-Q2
Increased
51,333
+44.0%
$930,0000.0%$16.95
34
2020-Q1
Increased
35,661
+42.4%
$557,0000.0%$14.63
33
2019-Q4
Increased
25,046
+28.1%
$492,0000.0%$18.41
30
2019-Q3
New
19,556
-
$339,0000.0%$16.23
33

Other major holders of TAK: BNP PARIBAS FINANCIAL MARKETS, GLENVIEW CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used